Literature DB >> 29671245

Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.

Hiroki Hosoi1, Toshiki Mushino1, Akinori Nishikawa1, Hisako Hashimoto2, Shogo Murata1, Kazuo Hatanaka1,3, Shinobu Tamura1, Nobuyuki Hanaoka1,4, Norio Shimizu5, Takashi Sonoki6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29671245     DOI： 10.1007/s12185-018-2456-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  3 in total

1.  Pretransplantation Anti-CCR4 Antibody Mogamulizumab Against Adult T-Cell Leukemia/Lymphoma Is Associated With Significantly Increased Risks of Severe and Corticosteroid-Refractory Graft-Versus-Host Disease, Nonrelapse Mortality, and Overall Mortality.

Authors:  Shigeo Fuji; Yoshitaka Inoue; Atae Utsunomiya; Yukiyoshi Moriuchi; Kaoru Uchimaru; Ilseung Choi; Eiichi Otsuka; Hideho Henzan; Koji Kato; Takeaki Tomoyose; Hisashi Yamamoto; Saiko Kurosawa; Ken-Ichi Matsuoka; Takuhiro Yamaguchi; Takahiro Fukuda
Journal:  J Clin Oncol       Date:  2016-08-09       Impact factor: 44.544

2.  Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia-lymphoma in Japan: interim results of postmarketing all-case surveillance.

Authors:  Kenji Ishitsuka; Satoshi Yurimoto; Kouichi Kawamura; Yukie Tsuji; Manabu Iwabuchi; Takeshi Takahashi; Kensei Tobinai
Journal:  Int J Hematol       Date:  2017-06-09       Impact factor: 2.319

3.  Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.

Authors:  Yukie Tsubokura; Atsushi Satake; Masaaki Hotta; Hideaki Yoshimura; Shinya Fujita; Yoshiko Azuma; Takahisa Nakanishi; Aya Nakaya; Tomoki Ito; Kazuyoshi Ishii; Shosaku Nomura
Journal:  Int J Hematol       Date:  2016-08-29       Impact factor: 2.319
  3 in total
  1 in total

Review 1.  Monoclonal Antibodies in Dermatooncology-State of the Art and Future Perspectives.

Authors:  Malgorzata Bobrowicz; Radoslaw Zagozdzon; Joanna Domagala; Roberta Vasconcelos-Berg; Emmanuella Guenova; Magdalena Winiarska
Journal:  Cancers (Basel)       Date:  2019-09-24       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.